Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2b, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of the Efficacy and Safety of Brensocatib in Participants With Chronic Rhinosinusitis Without Nasal Polyps - The BiRCh Study

NCT06013241 is registered in ClinicalTrials.gov with Insmed Incorporated as lead sponsor.

NCT NCT06013241
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06013241 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of the Efficacy and Safety of Brensocatib in Participants With Chronic Rhinosinusitis Without Nasal Polyps - The BiRCh Study
Lead sponsor
Insmed Incorporated
Phase
Phase 2
Overall status
Completed
Start date
October 30, 2023
Completion date
October 30, 2025
Enrollment
288 (actual)
Sites
100

Conditions

As the registry lists them; a condition with its own page is linked.

chronic rhinosinusitis without nasal polyps